Your browser doesn't support javascript.
loading
Promyelocytic leukemia protein is a restriction factor for Junín virus independently of Z matrix protein.
Giovannoni, Federico; Vazquez, Cecilia A; Thomas, Pablo; Gómez, Ricardo M; García, Cybele C.
Afiliação
  • Giovannoni F; Laboratorio de Estrategias Antivirales, Instituto de Química Biológica, Facultad de Ciencias Exactas y Naturales, IQUIBICEN, UBA-CONICET, Buenos Aires, Argentina.
  • Vazquez CA; Laboratorio de Estrategias Antivirales, Instituto de Química Biológica, Facultad de Ciencias Exactas y Naturales, IQUIBICEN, UBA-CONICET, Buenos Aires, Argentina.
  • Thomas P; Instituto de Biotecnología y Biología Molecular, CONICET-UNLP, La Plata, Argentina.
  • Gómez RM; Instituto de Biotecnología y Biología Molecular, CONICET-UNLP, La Plata, Argentina. Electronic address: rmg@biol.unlp.edu.ar.
  • García CC; Laboratorio de Estrategias Antivirales, Instituto de Química Biológica, Facultad de Ciencias Exactas y Naturales, IQUIBICEN, UBA-CONICET, Buenos Aires, Argentina. Electronic address: cygarcia@qb.fcen.uba.ar.
Biochem Biophys Res Commun ; 606: 168-173, 2022 05 28.
Article em En | MEDLINE | ID: mdl-35364325
ABSTRACT
The New World (NW) mammarenavirus Junín (JUNV) is the etiological agent of Argentine hemorrhagic fever, a human endemic disease of Argentina. Promyelocytic leukemia protein (PML) has been reported as a restriction factor for several viruses although the mechanism/s behind PML-mediated antiviral effect may be diverse and are a matter of debate. Previous studies have reported a nuclear to cytoplasm translocation of PML during the murine Old World mammarenavirus lymphocytic choriomeningitis virus (LCMV) infection. This translocation was found to be mediated by the viral Z protein. Here, we show that PML restricts JUNV infection in human A549 cells. However, in contrast to LCVM, JUNV infection enhances PML expression and PML is not translocated to the cytoplasm neither it colocalizes with JUNV Z protein. Our study demonstrates that a NW mammarenavirus as JUNV interacts differently with the antiviral protein PML than LCMV.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Junin / Proteína da Leucemia Promielocítica / Febre Hemorrágica Americana Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Junin / Proteína da Leucemia Promielocítica / Febre Hemorrágica Americana Idioma: En Ano de publicação: 2022 Tipo de documento: Article